News Publications
Topic: RSS FeedZocor prices go through changes as patent expires tonight
USA TODAY, June, 2006 by Rita Rubin
For months, health plans have eagerly anticipated the Friday debut of a generic version of Zocor, Merck's blockbuster cholesterol-lowering statin. Typically, generics cost 30% to 50% less than the equivalent brand-name drugs, so switching patients from Zocor, with $4.4 billion in sales last year, to generic simvastatin could result in savings of more than a billion dollars a year.
Zocor's patent expires tonight, and three generic versions are expected to enter the market Friday. Yet, at least for the next six months, some health plans will encourage patients to stay on Zocor because Merck has lowered the price to compete with generics.
"We've decided that we're going to continue to sell Zocor during those six months, and we're going to price it competitively," says...
Most Recent News Articles
- ARAB EUROPEAN RELATIONS - Dec 22 - Russia Denies Selling Missile System To Iran
- EGYPT - Dec 29 - Opposition Says Mubarak Blessed Israeli Attacks
- ARAB AFFAIRS - Dec 22 - Syria Will Eventually Move To Direct Talks With Israel
- ARAB AFFAIRS - Dec 30 - GCC Denounces Massacre
- ARAB ISRAELI RELATIONS - Israel Issues An Appeal To Palestinians In Gaza
Most Recent News Publications
Most Popular News Articles
- How Florida ended up landing Urban Meyer
- Michael Jackson: crowned in Africa, pop music king tells real story of controversial trip - includes related interview - Cover Story
- Jordie's shocking secret diary of sex abuse by Michael Jackson
- Michael Jackson gives first live interview to Oprah Winfrey - Cover Story
- 9 questions to ask your new lover: what you were afraid to ask, but always wanted to know

